TYRNAEVAEN JA MUHOKSEN MAAKAASUISTA = SUR LES GAZ NATURELS DE TYRNAEVAE ET DE MUHOSHEIKKINEN A.1972; GEOLOGI; FINL. ; 1972, VOL. 24, NUM. 0008, P. 73 A 76Serial Issue

GEOLOGICAL SURVEY OF FINLAND RADIOCARBON MEASUREMENTS 5.HEIKKINEN A.1971; RADIOCARBON; USA; 1971, VOL. 13, NUM. 0002, P. 432 A 441Miscellaneous

RADIOHIILIMENETELMAEN KAEYTOESTAE MOREENIN SISAELTAEMAEN VANHAN HIILIAINEKSEN AJOITUKSESSA. = DATATION AU RADIOCARBONE D'UN ACIEN CHARBON DE BOIS CONTENU DANS UNE MORAINEHEIKKINEN A.1975; GEOLOGI; FIN; 1975, VOL. 27, NUM. 0004, P. 51 A 53Serial Issue

KOTALAHDEN KAIVOKSEN KAASUN ALKUPERAESTAE = ORIGINE DU GAZ NATUREL DANS LA MINE DE KOTALAHTIHEIKKINEN A.1973; VUORITEOLLISUUS; FINL. ; 1973, VOL. 31, NUM. 0001, P. 36 A 37Serial Issue

Betongs plasticering: betong met olika tillsatsmaterial = Béton plastifié: béton avec des adjuvants minérauxHEIKKINEN, A.Nordisk betong. 1985, Num 2, pp 19-20, issn 0029-1307Article

GEOLOGICAL SURVEY OF FINLAND RADIOCARBON MEASUREMENTS VII.HEIKKINEN A; AIKAA O.1977; RADIOCARBON; U.S.A.; DA. 1977; VOL. 19; NO 2; PP. 263-279; BIBL. 18 REF.Article

HISTOLOGICAL GRADING OF TRANSITIONAL CELL TUMOURS OF THE BLADDER VALUE OF HISTOLOGICAL GRADING (WHO) IN PROGNOSISCOLLAN Y; MAKINEN J; HEIKKINEN A et al.1979; EUROP. UROL.; CHE; DA. 1979; VOL. 5; NO 5; PP. 311-318; BIBL. 21 REF.Article

TRANSITIONAL CELL TUMOURS OF THE URINARY BLADDER. THE HISTOLOGICAL GRADE (WHO) AND THE CLINICAL STAGE (LIICC).MAKINEN J; COLLAN Y; HEIKKINEN A et al.1978; EUROP. UROL.; SWITZ.; DA. 1978; VOL. 4; NO 3; PP. 176-181; BIBL. 21 REF.Article

GEOLOGICAL SURVEY OF FINLAND RADIOCARBON MEASUREMENTS. VI.HEIKKINEN A; KOIVISTO AK; AIKAA O et al.1974; RADIOCARBON; U.S.A.; 1974, VOL. 16, NUM. 0002, P. 252 A 268Serial Issue

TISSUE ANTIBODIES IN MALIGNANT AND BENIGN UROGENITAL DISEASE.KURKI P; LINDER E; MIETTINEN A et al.1977; INTERNATION. J. CANCER; SWITZ.; DA. 1977; VOL. 19; NO 3; PP. 332-336; ABS. FR.; BIBL. 19 REF.Article

RHEUMATOID FACTOR AS AN INDICATOR OF SERUM BLOCKING ACTIVITY AND TUMOUR RECURRENCES IN BLADDER TUMOURSPYRHONEN S; TIMONEN T; HEIKKINEN A et al.1976; EUROP. J. CANCER; G.B.; DA. 1976; VOL. 12; NO 2; PP. 87-94; BIBL. 1 P. 1/2Article

Practical aspects concerning moisture gradient calendering : Optimizing the performance of optiload multinip calenderHEIKKINEN, A; LINNONMAA, P; DIEBEL, M et al.Wochenblatt für Papierfabrikation. 1999, Vol 127, Num 10, pp 680-682, issn 0043-7131Conference Paper

A method for transferring data from design to manufacturingHEIKKINEN, A; KORPELA, T; LEINONEN, T et al.Schriftenreihe WDK. 1997, pp 619-622, isbn 951-722-788-4, 3VolConference Paper

Interpleural analgesia for postoperative pain relief in renal surgery patientsKAUKINEN, S; KAUKINEN, L; KATAJA, J et al.Scandinavian journal of urology and nephrology. 1994, Vol 28, Num 1, pp 39-43, issn 0036-5599Article

Improved line spectral frequency estimation through anti-aliasing filteringAL-NAIMI, K; VILLETTE, S; KONDOZ, A et al.IEE proceedings. Vision, image and signal processing. 2006, Vol 153, Num 5, pp 610-617, issn 1350-245X, 8 p.Article

Long-term vitamin D₃ supplementation may have adverse effects on serum lipids during postmenopausal hormone replacement therapyHEIKKINEN, A.-M; TUPPURAINEN, M. T; NISKANEN, L et al.European journal of endocrinology. 1997, Vol 137, Num 5, pp 495-502, issn 0804-4643Article

Transplacental Transfer of Nitrosodimethylamine in Perfused Human PlacentaANNOLA, K; HEIKKINEN, A. T; PARTANEN, H et al.Placenta (Eastbourne). 2009, Vol 30, Num 3, pp 277-283, issn 0143-4004, 7 p.Article

Small subgroup of aggressive, highly proliferative prostatic carcinomas defineb by p53 accumulationVISAKORPI, T; KALLIONIEMI, O.-P; HEIKKINEN, A et al.Journal of the National Cancer Institute. 1992, Vol 84, Num 11, pp 883-887, issn 0027-8874Article

Is the response of serum lipids and lipoproteins to postmenopausal hormone replacement therapy modified by ApoE genotype?HEIKKINEN, A.-M; NISKANEN, L; RYYNÄNEN, M et al.Arteriosclerosis, thrombosis, and vascular biology. 1999, Vol 19, Num 2, pp 402-407, issn 1079-5642Article

Postmenopausal hormone replacement therapy and autoantibodies against oxidized LDLHEIKKINEN, A.-M; NISKANEN, L; YLÄ-HERTTUALA, S et al.Maturitas (Amsterdam). 1998, Vol 29, Num 2, pp 155-161, issn 0378-5122Article

Flow cytometric analysis of DNA ploidy and S-phase fraction from prostatic carcinomas : implications for prognosis and response to endocrine therapyVISAKORPI, T; KALLIONIEMI, O.-P; PARONEN, I. Y. I et al.British journal of cancer. 1991, Vol 64, Num 3, pp 578-582, issn 0007-0920Article

Pharmaceutical thrombosis prophylaxis, bleeding complications and thromboembolism in a national cohort of hysterectomy for benign diseaseBRUMMER, T. H. I; HEIKKINEN, A; JALKANEN, J et al.Human reproduction (Oxford. Print). 2012, Vol 27, Num 6, pp 1628-1636, issn 0268-1161, 9 p.Article

HRT and Vit D in prevention of non-vertebral fractures in postmenopausal women; a 5 year randomized trialKOMULAINEN, M. H; KRÖGER, H; TUPPURAINEN, M. T et al.Maturitas (Amsterdam). 1998, Vol 31, Num 1, pp 45-54, issn 0378-5122Article

Vitamin D and HRT : No benefit additional to that of HRT alone in prevention of bone loss in early postmenopausal women. A 2.5-year randomized placebo-controlled studyKOMULAINEN, M; TUPPURAINEN, M. T; KRÖGER, H et al.Osteoporosis international. 1997, Vol 7, Num 2, pp 126-132, issn 0937-941XArticle

Biochemical bone markers and bone mineral density during postmenopausal hormone replacement therapy with and without vitamin D₃ : A prospective, controlled, randomized studyHEIKKINEN, A.-M; PARVIAINEN, M; NISKANEN, L et al.The Journal of clinical endocrinology and metabolism. 1997, Vol 82, Num 8, pp 2476-2482, issn 0021-972XArticle